microRNA和lncRNA在银屑病中的研究进展

doi:10.3760/cma.j.issn.0412-4030.2019.05.016

摘要/Abstract

摘要： 【摘要】银屑病是一种常见的慢性炎症性皮肤病，目前普遍认为该病是在多基因遗传背景下主要由T细胞介导的免疫异常性疾病。近年研究发现，microRNA和lncRNA能够参与多种炎症免疫性疾病的发生发展过程。已证实microRNA和lncRNA能够通过调控角质形成细胞增殖与分化、炎症因子释放以及血管形成等功能参与银屑病的发病过程。本文综述microRNA和lncRNA在银屑病中的研究进展。

关键词: 银屑病, 微RNAs, 长链非编码RNAs

Abstract: 【Abstract】 Psoriasis is a common chronic inflammatory skin disease, and commonly considered as a T cell?mediated abnormal immune disease with genetic predisposition at present. Recent studies have indicated that microRNA and lncRNA play important roles in occurrence and development of a variety of inflammatory immune diseases. It has been confirmed that microRNA and lncRNA participate in the occurrence of psoriasis by regulating the proliferation and differentiation of keratinocytes, release of inflammatory factors, and angiopoiesis. This review summarizes research advances in roles of microRNA and lncRNA in psoriasis.

Key words: Psoriasis, MicroRNAs, LncRNAs

胡煜陈敏顾恒. microRNA和lncRNA在银屑病中的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 350-353.

Hu Yu, Chen Min, Gu Heng. MicroRNA and lncRNA in psoriasis[J]. Chinese Journal of Dermatology, 2019, 52(5): 350-353.

参考文献 36

［1］	Nestle FO, Kaplan DH, Barker J. Psoriasis［J］. N Engl J Med, 2009,361（5）:496⁃509. doi: 10.1056/NEJMra0804595.
［2］	Wang J, Song YX, Wang ZN. Non⁃coding RNAs in gastric cancer［J］. Gene, 2015,560（1）:1⁃8. doi: 10.1016/j.gene.2015.02. 004.
［3］	Deng X, Su Y, Wu H, et al. The role of microRNAs in autoimmune diseases with skin involvement［J］. Scand J Immunol, 2015,81（3）:153⁃165. doi: 10.1111/sji.12261.
［4］	Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?［J/OL］. PLoS One, 2007,2（7）:e610. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC 1905940/. doi: 10.1371/journal.pone.0000610.
［5］	Xu Y, Ji Y, Lan X, et al. miR⁃203 contributes to IL⁃17⁃induced VEGF secretion by targeting SOCS3 in keratinocytes［J］. Mol Med Rep, 2017,16（6）:8989⁃8996. doi: 10.3892/mmr.2017.7759.
［6］	Primo MN, Bak RO, Schibler B, et al. Regulation of pro⁃inflammatory cytokines TNFα and IL24 by microRNA⁃203 in primary keratinocytes［J］. Cytokine, 2012,60（3）:741⁃748. doi: 10.1016/j.cyto.2012.07.031.
［7］	Wei T, Xu N, Meisgen F, et al. Interleukin⁃8 is regulated by miR⁃203 at the posttranscriptional level in primary human keratinocytes［J/OL］. Eur J Dermatol, 2013. ［2018⁃04⁃02］. https://www.jle.com/fr/revues/ejd/e⁃docs/interleukin_8_is_regulated_by_mir_203_at_the_posttranscriptional_level_in_primary_human_keratinocytes_296259/article.phtml. doi: 10.1684/ejd.2013.1997.
［8］	Meisgen F, Xu Landén N, Wang A, et al. MiR⁃146a negatively regulates TLR2⁃induced inflammatory responses in keratino⁃cytes［J］. J Invest Dermatol, 2014,134（7）:1931⁃1940. doi: 10. 1038/jid.2014.89.
［9］	Hermann H, Runnel T, Aab A, et al. MiR⁃146b probably assists miRNA⁃146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis［J］. J Invest Dermatol, 2017,137（9）:1945⁃1954. doi: 10.1016/j.jid.2017.05.012.
［10］	Srivastava A, Nikamo P, Lohcharoenkal W, et al. MicroRNA⁃146a suppresses IL⁃17⁃mediated skin inflammation and is genetically associated with psoriasis［J］. J Allergy Clin Immunol, 2017,139（2）:550⁃561. doi: 10.1016/j.jaci.2016.07.025.
［11］	Meisgen F, Xu N, Wei T, et al. MiR⁃21 is up⁃regulated in psoriasis and suppresses T cell apoptosis［J］. Exp Dermatol, 2012,21（4）:312⁃314. doi: 10.1111/j.1600⁃0625.2012.01462.x.
［12］	Guinea⁃Viniegra J, Jiménez M, Schonthaler HB, et al. Targeting miR⁃21 to treat psoriasis［J］. Sci Transl Med, 2014,6（225）:225re1. doi: 10.1126/scitranslmed.3008089.
［13］	Xu N, Meisgen F, Butler LM, et al. MicroRNA⁃31 is over⁃expressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40［J］. J Immunol, 2013,190（2）:678⁃688. doi: 10.4049/jimmunol.1202695.
［14］	Yan S, Xu Z, Lou F, et al. NF⁃κB⁃induced microRNA⁃31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis［J］. Nat Commun, 2015,6:7652. doi: 10.1038/ncomms8652.
［15］	Borska L, Andrys C, Chmelarova M, et al. Roles of miR⁃31 and endothelin⁃1 in psoriasis vulgaris: pathophysiological functions and potential biomarkers［J］. Physiol Res, 2017,66（6）:987⁃992.
［16］	Xu L, Leng H, Shi X, et al. MiR⁃155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis［J］. Biomed Pharmacother, 2017,90:524⁃530. doi: 10. 1016/j.biopha.2017.03.105.
［17］	Hou RX, Liu RF, Zhao XC, et al. Increased miR⁃155⁃5p in dermal mesenchymal stem cells of psoriatic patients: comparing the microRNA profile by microarray［J］. Genet Mol Res, 2016,15（3）. doi: 10.4238/gmr. 15038631.
［18］	Xu N, Brodin P, Wei T, et al. MiR⁃125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2［J］. J Invest Dermatol, 2011,131（7）:1521⁃1529. doi: 10.1038/jid.2011.55.
［19］	Wei T, Folkersen L, Biskup E, et al. Ubiquitin⁃specific peptidase 2 as a potential link between microRNA⁃125b and psoriasis［J］. Br J Dermatol, 2017,176（3）:723⁃731. doi: 10.1111/bjd.14916.
［20］	Jiang M, Sun Z, Dang E, et al. TGFβ/SMAD/microRNA⁃486⁃3p signaling axis mediates keratin 17 and keratinocyte hyperproliferation in psoriasis［J］. J Invest Dermatol, 2017,137（10）:2177⁃2186. doi: 10.1016/j.jid.2017.06.005.
［21］	Ichihara A, Jinnin M, Yamane K, et al. microRNA⁃mediated keratinocyte hyperproliferation in psoriasis vulgaris［J］. Br J Dermatol, 2011,165（5）:1003⁃1010. doi: 10.1111/j.1365⁃2133. 2011.10497.x.
［22］	Chowdhari S, Sardana K, Saini N. miR⁃4516, a microRNA downregulated in psoriasis inhibits keratinocyte motility by targeting fibronectin/integrin α9 signaling［J］. Biochim Biophys Acta Mol Basis Dis, 2017,1863（12）:3142⁃3152. doi: 10.1016/j.bbadis.2017.08.014.
［23］	St Laurent G, Wahlestedt C, Kapranov P. The Landscape of long noncoding RNA classification［J］. Trends Genet, 2015,31（5）:239⁃251. doi: 10.1016/j.tig.2015.03.007.
［24］	Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs［J］. Mol Cell, 2011,43（6）:904⁃914. doi: 10.1016/j.molcel. 2011.08.018.
［25］	Tsoi LC, Iyer MK, Stuart PE, et al. Analysis of long non⁃coding RNAs highlights tissue⁃specific patterns and epigenetic profiles in normal and psoriatic skin［J］. Genome Biol, 2015,16:24. doi: 10.1186/s13059⁃014⁃0570⁃4.
［26］	Ahn R, Gupta R, Lai K, et al. Network analysis of psoriasis reveals biological pathways and roles for coding and long non⁃coding RNAs［J］. BMC Genomics, 2016,17（1）:841. doi: 10.1186/ s12864⁃016⁃3188⁃y.
［27］	Gupta R, Ahn R, Lai K, et al. Landscape of long noncoding RNAs in psoriatic and healthy skin［J］. J Invest Dermatol, 2016,136（3）:603⁃609. doi: 10.1016/j.jid.2015.12.009.
［28］	Szegedi K, Göblös A, Bacsa S, et al. Expression and functional studies on the noncoding RNA, PRINS［J］. Int J Mol Sci, 2012,14（1）:205⁃225. doi: 10.3390/ijms14010205.
［29］	Sonkoly E, Bata⁃Csorgo Z, Pivarcsi A, et al. Identification and characterization of a novel, psoriasis susceptibility⁃related noncoding RNA gene, PRINS［J］. J Biol Chem, 2005,280（25）:24159⁃24167. doi: 10.1074/jbc.M501704200.
［30］	Szegedi K, Sonkoly E, Nagy N, et al. The anti⁃apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non⁃coding RNA, PRINS［J］. Exp Dermatol, 2010,19（3）:269⁃278. doi: 10.1111/j.1600⁃0625.2010.01066.x.
［31］	Széll M, Danis J, Bata⁃Csörgö Z, et al. PRINS, a primate⁃specific long non⁃coding RNA, plays a role in the keratinocyte stress response and psoriasis pathogenesis［J］. Pflugers Arch, 2016,468（6）:935⁃943. doi: 10.1007/s00424⁃016⁃1803⁃z.
［32］	Danis J, Göblös A, Bata⁃Csörgö Z, et al. PRINS non⁃coding RNA regulates nucleic acid⁃induced innate immune responses of human keratinocytes［J］. Front Immunol, 2017,8:1053. doi: 10.3389/fimmu.2017.01053.
［33］	Holm SJ, Sánchez F, Carlén LM, et al. HLA⁃Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3［J］. Acta Derm Venereol, 2005,85（1）:2⁃8. doi: 10.1080/00015550410023527.
［34］	Wu GC, Pan HF, Leng RX, et al. Emerging role of long noncoding RNAs in autoimmune diseases［J］. Autoimmun Rev, 2015,14（9）:798⁃805. doi: 10.1016/j.autrev.2015.05.004.
［35］	Li B, Tsoi LC, Swindell WR, et al. Transcriptome analysis of psoriasis in a large case⁃control sample: RNA⁃seq provides insights into disease mechanisms［J］. J Invest Dermatol, 2014,134（7）:1828⁃1838. doi: 10.1038/jid.2014.28.
［36］	Qiao M, Li R, Zhao X, et al. Up⁃regulated lncRNA⁃MSX2P1 promotes the growth of IL⁃22⁃stimulated keratinocytes by inhibiting miR⁃6731⁃5p and activating S100A7［J］. Exp Cell Res, 2018,363（2）:243⁃254. doi: 10.1016/j.yexcr.2018.01.014.

[1]	陈怡雯苏婷苏忠兰. 银屑病与STAT3[J]. 中华皮肤科杂志, 2019, 52(7): 502-505.
[2]	夏永华张彩凤李敏刘冬胡华张孟杰程赛. 微小RNA-373表达下调对皮肤鳞状细胞癌A431细胞周期和凋亡的影响[J]. 中华皮肤科杂志, 2019, 52(7): 494-497.
[3]	苏蓓蓓甘泉甘才斌. 二甲双胍对银屑病样小鼠模型皮损炎症状态及磷酸化Stat3蛋白表达的影响[J]. 中华皮肤科杂志, 2019, 52(7): 475-480.
[4]	覃慧郑捷. 鞘氨醇1-磷酸盐受体拮抗剂（FTY720）抑制皮肤中分泌白细胞介素17的γδT细胞治疗银屑病的机制研究[J]. 中华皮肤科杂志, 2019, 52(6): 395-400.
[5]	王丽玮罗玲玲崔盘根李岷. 肠道菌群与银屑病关系的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 357-360.
[6]	潘家旭周婧. 核因子κB信号通路在银屑病中的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 361-363.
[7]	曾菁莘田歆朱慧兰张锡宝林玲张丽丹刘炜钰罗权. 微小RNA-148a-3p在寻常型银屑病患者外周血CD4⁺ T淋巴细胞中的表达及临床意义[J]. 中华皮肤科杂志, 2019, 52(4): 231-235.
[8]	中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2018简版）[J]. 中华皮肤科杂志, 2019, 52(4): 223-230.
[9]	中国医师协会皮肤科医师分会规范化诊疗工作委员会中国医学装备协会皮肤病与皮肤美容专业委员会皮肤外科装备学组和皮肤光治疗学组. 窄谱中波紫外线家庭光疗临床应用专家共识[J]. 中华皮肤科杂志, 2019, 52(3): 156-161.
[10]	高祎濛晋红中. 精神神经因素在银屑病发病中的作用[J]. 中华皮肤科杂志, 2019, 52(3): 204-207.
[11]	关欣张春雷. 英夫利西单抗长疗程治疗中重度寻常性银屑病的疗效评价[J]. 中华皮肤科杂志, 2019, 52(2): 86-89.
[12]	彭琛陈文娟于宁高芸璐易雪梅丁杨峰. 银屑病皮肤及肠道微生态研究进展[J]. 中华皮肤科杂志, 2019, 52(2): 135-137.
[13]	王刚. 皮肤科生物制剂的主要不良反应及对策[J]. 中华皮肤科杂志, 2019, 52(2): 77-80.
[14]	胡煜栾超练霓郝志敏孙玉洁王焱顾恒陈敏. 银屑病患者血浆中前蛋白转化酶枯草溶菌素9的表达及对外周血CD4+ T细胞活化的影响[J]. 中华皮肤科杂志, 2019, 52(2): 90-93.
[15]	熊娟娟毕健平孙德祥李念鲁巧云. 甲真菌病和甲银屑病的皮肤镜特征分析[J]. 中华皮肤科杂志, 2019, 52(2): 106-110.